Comparative trial of azithromycin and ciprofloxacin in the treatment of gonorrhea

Journal of Chemotherapy

Volumn 9, Issue 4, 1997, Pages 263-266

  Gruber, F ^a   Brajac, I ^a   Jonjic, A ^b   Grubisic Greblo H ^b   Lenkovic, M ^a   Stasic A ^a  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Azithromycin; Ciprofloxacin; Gonorrhea; Sexually transmitted disease; Venereal disease

Indexed keywords

AZITHROMYCIN; CIPRINOL; CIPROFLOXACIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GONORRHEA; GRAM STAINING; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; NAUSEA; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; SAILOR; SINGLE BLIND PROCEDURE; TOURISM; TRAVEL; VERTIGO; VOMITING;

EID: 0030740651     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.4.263     Document Type: Article

References (12)

1. Mohar N, Gruber F. Gonorrhoea to-day. Medicina 1979; 16: 81-88.
2. Gruber F, Grubisic-Greblo H, Jonjic A, Markusic J. Treatment of gonococcal and chlamydial urethritis with azithromycin or doxycycline. Chron Derm 1995; 5: 215-218.
3. Jones RN, Gavan TN, Thornsberry C et al. Standardization ot disk diffusion and dilution susceptibility tests for Neisseria gonorrboeae: interpretative criteria and quality control guidelines for cefriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol 1989; 27: 2758-2766.
4. Lassus A. Comparative studies ot azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicrob Chemother 1990; 25 (Suppl E): 115-121.
5. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single dose azithromycin treatment of gonorrhoea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21: 43-46.
6. Waugh M. Open study of the safety and efficacy of a single dose of azithromycin tor the treatment of uncomplicated gonorrhoea in men and women. J Antimicrob Chemother 1993; 31 ( Suppl E): 193-198.
7. Handsfield HH, Dalu ZA, Martin DA, Douglas JM, McCarty JM, Schlossberg D. Multicentric trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis 1994; 21: 107-111.
8. Gruber F, Stašic A, Lenkovic M, Brajac I. Azithromycin in the treatment of chlamydial urethritis in seamen. In Stary ed. Proc. Third Meeting of the European Society for Chlamydia Research, Vienna 1996: 453.
9. Lewis DA, Ison CA, Livermore DM, Chen HY, Hooi AY, Wisdom AR. A one-year survey ot Neisseria gonorrboeae isolated from patients attending an east London genitourinary medicine clinic: susceptibility patterns and patients' characteristics. Genitourin Med 1995; 71: 13-17.
10. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 (Suppl A): 73-82.
11. Odugbemi T, Oyewole F, Isichei CS, Onwukeme KE, Adeyemi-Doro FA. Single oral dose of azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation. West Afr J Med 1993; 12: 136-140.
12. Tomazic J. Azithromycin and the immune system. Medicus 1994; 3: 167-172.